Kulkarni Sandeep Chidambar's Form 4 filing
Tourmaline Bio, Inc. (TRML) · filed Nov 20, 2023
- Accession no.
- 0001209191-23-056128
- Filed
- Nov 20, 2023
- Trade date
- Nov 17, 2023
- Filing delay
- 3 days
- Rule 10b5-1 plan
- Not checked
This filing lists 1 non-derivative transaction and 0 derivative transactions. Open-market purchases total $68.0K. It was filed 3 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Kulkarni Sandeep ChidambarCIK 0001945691 | Director, Officer (CEO) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Nov 17, 2023 | Common Stock | PPurchaseAcquired | +4,000 | $16.99 | +$67,960 | 729,735 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.